ask="6.80"
ask_size="200"
average_daily_volume="212013"
bid="N/A"
bid_size="N/A"
book_value="3.23"
change="-0.10"
change_from_200_day_moving_average="-5.28"
change_from_50_day_moving_average="-0.93"
change_from_52_week_high="-12.70"
change_From_52_week_low="0.12"
change_in_percent="-1.96%"
close="5.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.50"
ebitda="-19.10M"
eps_estimate_current_year="-2.77"
eps_estimate_next_quarter="-0.92"
eps_estimate_next_year="-2.52"
ex_dividend_date="N/A"
float_shares="5820000"
high="5.25"
high_52_weeks="17.70"
last_trade_date="1/24/2017"
last_trade_price="5.00"
last_trade_size="100"
last_trade_time="3:59pm"
low="4.95"
low_52_weeks="4.88"
market_capitalization="39.09M"
moving_average_200_day="10.28"
moving_average_50_day="5.93"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.70"
open="5.11"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-51.35%"
percent_change_from_50_day_moving_average="-15.73%"
percent_change_from_52_week_high="-71.75%"
percent_change_from_52_week_low="+2.56%"
previous_close="5.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.58"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7817000"
short_ratio="1.46"
stock_exchange="NCM"
symbol="TRIL"
volume="60359"
weeks_range_52="4.88 - 17.70"
